Aptose Biosciences Inc (APTO)

Schlusskurs vom Vortag:

$1.19

Offen:

$1.1901

24-Stunden-Volumen:

30,874

Marktkapitalisierung:

$19.50M

Einnahmen:

-

Nettoeinkommen (Verlust:

$-51.21M

KGV:

-0.1535

EPS:

-7.82

Netto-Cashflow:

$-44.62M

1W Leistung:

-1.64%

1M Leistung:

-16.67%

6M Leistung:

-59.87%

1J Leistung:

+126.84%

1-Tages-Spanne:

$1.19

$1.23

52-Wochen-Spanne:

$0.36

$6.6001

Aptose Biosciences Inc Stock (APTO) Company Profile

Firmenname

Aptose Biosciences Inc

Sektor

Healthcare (1213)

Branche

Biotechnology (699)

Telefon

-

Adresse

251 Consumers Road, Suite 1105, Toronto, ON

Mitarbeiter

41

Twitter

Nächster Verdiensttermin

2024-05-06

Neueste SEC-Einreichungen

APTO's Discussions on Twitter

Aptose Biosciences Inc Stock (APTO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2020-10-19	Eingeleitet	Cantor Fitzgerald	Overweight
2020-09-22	Eingeleitet	Alliance Global Partners	Buy
2020-02-20	Eingeleitet	Maxim Group	Buy
2020-02-06	Bestätigt	H.C. Wainwright	Buy
2020-01-09	Eingeleitet	Piper Sandler	Overweight
2019-03-01	Eingeleitet	RBC Capital Mkts	Outperform
2018-11-16	Eingeleitet	B. Riley FBR	Buy
2017-12-13	Bestätigt	H.C. Wainwright	Buy
2017-10-23	Fortgesetzt	ROTH Capital	Buy
2017-09-07	Hochstufung	H.C. Wainwright	Neutral → Buy
2017-06-08	Eingeleitet	Rodman & Renshaw	Neutral

Alle ansehen

Aptose Biosciences Inc Aktie (APTO) Neueste Nachrichten

What Makes Aptose Biosciences (APTO) a New Buy Stock

Zacks Investment Research

Aptose Reports Results for the Fourth Quarter and Full Year 2023

GlobeNewswire Inc.

Aptose to Report Fourth Quarter and Year End 2023 Financial Results and Provide Corporate Update on Tuesday, March 26, 2024

GlobeNewswire Inc.

Assertio (ASRT) Stock Plunges 65% in 3 Months: Here's Why

Zacks Investment Research

Aptose Announces Closing of $9.7 Million Public Offering and Concurrent $4 Million Private Placement with Hanmi Pharmaceutical, Including Full Exercise of Over-Allotment Option

GlobeNewswire Inc.

Aptose Announces Pricing of $8.4 Million Public Offering and a Concurrent $4 Million Private Placement with Hanmi Pharmaceutical

GlobeNewswire Inc.

Finanzdaten der Aptose Biosciences Inc-Aktie (APTO)

Aptose Biosciences Inc (APTO) Nettogewinn 2024

Aptose Biosciences Inc (APTO) Free Cashflow 2024

Aptose Biosciences Inc (APTO) Gewinn je Aktie 2024